PMID: 7020738Jul 1, 1981Paper

Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.)

British Journal of Cancer

Abstract

Between 1967 and 1978 a Phase III cooperative study was performed in polycythaemia vera (PCV) patients who had not been treated previously with any specific therapy other than phlebotomy. 293 patients were included and allocated at random for either radiophosphorus therapy (146) or busulphan treatment (147). Additional phlebotomies were indicated in both groups, to keep the haematocrit at 42-47%. 285 patients were evaluable after the study was completed, of whom 50% have an 8-year follow-up. Both groups were comparable with respect to age, clinical symptoms and haematological parameters immediately before randomization. The duration of the first remission and the overall survival were significantly better in the busulphan group. This difference remains significant after correction for differences between the two groups with respect to sex-ratio and phlebotomy before and the start of therapy. Busulphan induced a longer first remission (P less than 0.001) and a longer overall survival (P less than 0.02).

Citations

Jan 1, 1991·European Journal of Nuclear Medicine·C A Hoefnagel
Jan 1, 1987·Annals of the ICRP
Feb 1, 1986·British Journal of Haematology·J E Van de PetteG Wetherley-Mein
Feb 14, 2002·British Journal of Haematology·Jerry L Spivak
Jul 21, 2005·British Journal of Haematology·Mary F McMullinUNKNOWN General Haematology Task Force of the British Committee for Standards in Haematology
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ayalew Tefferi, William Vainchenker
May 20, 2015·Expert Review of Hematology·Jean-Jacques KiladjianSrdan Verstovsek
Oct 4, 2018·American Journal of Hematology·Ayalew Tefferi, Tiziano Barbui
Nov 1, 1987·British Journal of Haematology·Y NajeanJ D Rain
Sep 13, 2000·Drugs & Aging·P J van Genderen, M M Troost
Nov 15, 2002·International Journal of Hematology·Tiziano Barbui
Nov 25, 2003·Hematology·Jerry L SpivakMonia Marchetti
Mar 14, 2007·Hematological Oncology·Mary Frances McMullin
Jun 1, 2006·Current Hematologic Malignancy Reports·David Dingli, Ayalew Tefferi
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Magnus BjörkholmOla Landgren
May 13, 2014·European Journal of Haematology·Juan Carlos Hernández-Boluda, Montse Gómez
Oct 30, 2014·Expert Review of Hematology·Srdan Verstovsek, Rami S Komrokji
Apr 23, 2013·Journal of Thrombosis and Haemostasis : JTH·A CasiniT P Lecompte
Dec 31, 2015·Current Opinion in Hematology·Daniel Aruch, John Mascarenhas
Sep 1, 1982·British Journal of Haematology·I Brodsky
May 1, 1997·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·U KabothW Kaboth
Mar 23, 2002·Leukemia & Lymphoma·Ayalew Tefferi
Jan 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tiziano BarbuiUNKNOWN European LeukemiaNet
Jan 27, 2012·Current Hematologic Malignancy Reports·Giovanni BarosiVittorio Rosti
Jan 20, 2011·Current Opinion in Hematology·Animesh Pardanani, Ayalew Tefferi
Sep 13, 2015·Drugs·Kate McKeage
Jan 1, 1997·Hematology·T C Pearson, T Barbui

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.